Earnings Releases·Nov 3, 2026, 8:11 AM ET

Strata Critical Medical — Q3 2026 Earnings Summary

Total revenue rose 50.3% year-over-year to $74.1 million (8.5% pro forma), driven by a surge in Clinical revenue to $29.2 million, while Logistics revenue dipped 3.5% to $44.9 million; Adjusted EBITDA expanded 128% year-over-year to $9.6 million with a 13.0% margin.
Net loss narrowed to $(7.6) million from $(9.7) million year-over-year, supported by $8.6 million in Free Cash Flow and $9.5 million in operating cash flow.
The company reiterated full-year 2026 guidance for revenue ($285-295 million) and Adjusted EBITDA ($33-35 million) while announcing a $20 million share repurchase authorization and plans to accelerate acquisitions and return cash to shareholders.
Strategic milestones include the completed sale of the Passenger business, the acquisition of Keystone and three other entities in Q2 2026, and the receipt of a $15.3 million net earn-out from Joby Aviation stock.